血栓闭塞性脉管炎
- thromboangiitis obliterans
-
血栓闭塞性脉管炎(thromboangiitisobliterans,TAO)简称脉管炎,是一种以肢体中、小动脉为主的炎症性闭塞性疾病。
Thromboangiitis Obliterans ( Thromboangiitis Obliterans , TAO ) referred to as vasculitis , is a physical medium and small artery occlusion-based inflammatory diseases .
-
方法:本组7例中3例为血栓闭塞性脉管炎,4例为闭塞性动脉硬化。
Methods : There were 7 patients in this series . Three had thromboangiitis obliterans and 4 had arteriosclerosis obliterans .
-
VEGF在血栓闭塞性脉管炎大鼠模型中的表达及环磷酰胺应用观察
Expression of VEGF in Rat Model of Thromboangiitis Obliterans
-
血栓闭塞性脉管炎(TAO)35例,间歇性跛行16例,肢(趾)端坏疽19例。
There were 35 patients with thromboangiitis obliterans ( TAO ), including 16 IC and 19 limb gangrenes .
-
血栓闭塞性脉管炎患者血液TXB2和6-酮-PGF1α的变化
Change of TXB_2 and 6-Keto-PGF1_ α Levels in Patients with Thromboangiitis Obliterans
-
本文工作的主要创新之处:1.本文工作首次在月硅酸钠诱导的大鼠血栓闭塞性脉管炎模型观察Urocortin和CRH-R阻断剂对该疾病的影响。
The present work was the first study observing the influence of Urocortin and CRH-R antagonists on rat thromboangiitis obliterans model .
-
方法对1例患血栓闭塞性脉管炎7年的男性56岁患者,在胫骨内前方中段做一个纵长方形截骨(长120mm、宽20mm),然后安装可搬移骨块的装置。
Methods a longitudinal osteotomy in the middle tibial bone ( 120 mm long , 20 mm wide ) was prepared and then a bone external fixator which was able to move bone block was fixed .
-
发现Urocortin可通过CRH-R1促进大鼠血液高凝状态和脉管炎的发生发展,阻断CRH-R1可较显著改善大鼠血栓闭塞性脉管炎症状和体征。
It is found that Urocortin could promote development of the vasculitis and deteriorate rat blood hypercoagulable state via CRH-R1 ; blockade of CRH-R1 could significantly improve the signs and symptoms of rat thromboangiitis obliterans . 2 .
-
正负压治疗仪治疗血栓闭塞性脉管炎的疗效观察
Therapeutic effects on thromboangiitis obliterans patients treated with positive-negative pressure apparatus
-
药盒置入术治疗血栓闭塞性脉管炎的临床研究
A study of port-catheter system implantation in treatment of thrombo-angitis obliterans
-
闭塞性梅毒性主动脉炎静脉动脉化治疗血栓闭塞性脉管炎31例
The treatment of thromboangitis obliterans by venous arterialization in 31 patients
-
失败11例,下肢血栓闭塞性脉管炎,踝压指数预测腰交感神经节切除效果不可靠;
The predictive value of ankle index for lumbar sympathectomy was unsatisfactory .
-
眼针中药结合治疗血栓闭塞性脉管炎
Treatment of Angitis with Eye meedling Combined with Chinese Drug
-
血栓闭塞性脉管炎介入治疗的临床研究
The clinical study of interventional therapy in thrombo angitis obliterans
-
下肢动脉搭桥治疗晚期血栓闭塞性脉管炎
Late thromboangiitis obliterans of lower extremities treated by arterial bypass
-
血栓闭塞性脉管炎好发于20~0岁的青壮年男性,女性很少发病。
Thromboangiitis obliterans occur in the20-40-year-old young men and women rarely incidence .
-
血栓闭塞性脉管炎患者狼疮抗凝因子的研究
A study on lupus anticoagulants in buerger 's disease
-
血栓闭塞性脉管炎患者T细胞亚群的改变
Changes of T cell subset in patients with Tao
-
中西医结合治疗血栓闭塞性脉管炎33例
Chinese-Western-Combined Therapies for 33 Cases of Thrombo-embolia Angiitis
-
红外热温差检测血栓闭塞性脉管炎与局限性硬皮病16例
Inspection of temperature difference of buerger 's disease and localized scleroderma with infrared thermal
-
骨外固定器行胫骨迁移治疗血栓闭塞性脉管炎的护理
Nursing Care in Transverse Distraction of Tibia with External Fixation Apparatus for Buerger Disease
-
血栓闭塞性脉管炎病人血清中红细胞免疫调节因子的研究
Study on regulating factors for red cells immune in serum in patients with TAO
-
血栓闭塞性脉管炎的临床证治
Clinical Diagnosis and Treatment of Thrombotic Angiitis
-
He&Ne激光治疗对血栓闭塞性脉管炎患者免疫功能的影响
Effect of Treatment of He & Ne Laser on the Immunity in Patients with Thromboangiitis Obliterans
-
目的探讨血栓闭塞性脉管炎介入治疗的可行性及有效性。
Objective To evaluate the clinical feasibility and validity of interventional therapy in thrombo angitis obliterans .
-
目的回顾性分析静脉移植+静脉动脉化治疗血栓闭塞性脉管炎的临床效果。
Objectives To study the clinical result of venous transplant and venous as artery treat thrombosis vasculitis .
-
综合治疗血栓闭塞性脉管炎Ⅲ期47例临床观察
Observation of the Therapeutic Effect in Comprehensive Treatment of 47 Cases of Thromboangiitis Obliterans in Phase ⅲ
-
目的:观察化学性腰交感神经切除联合股动脉灌注治疗血栓闭塞性脉管炎的疗效。
Objective : To investigate the effects of chemical lumbar sympathectomy combined femoral artery puncture on thromboangiitis obliterans .
-
结论:溶栓丸3号是治疗3期血栓闭塞性脉管炎安全有效的药物。
Conclusion : RSP is a safe and effective remedy for treatment of TAO in the 3rd stage .
-
加减清营汤对血栓闭塞性脉管炎患者血脂和体液免疫的调节作用
Regulating Effect of Modified Qingying Decoction on Blood Lipid and Body Fluid Immunity in Patients with Vascular Occlusive Angiitis